Mark Meier

Senior Director of Marketing at Zevra Therapeutics

Speaker

Accomplished pharmaceutical and biotech leader with 23+ years of experience driving commercialization, strategic leadership, and launch excellence across organizations ranging from startups to global enterprises. Brings deep expertise in genetics, neurology, psychiatry, oncology, dermatology, and rare and ultra-rare diseases. Proven track record of developing and executing high-impact strategies, navigating complex regulatory environments, and building high-performing teams and partnerships to exceed corporate objectives. Successfully led the launch of two FDA-approved therapies within the past four years, overcoming significant regulatory challenges, including complex CRLs. Recent launches include treatments for Niemann-Pick disease type C, cisplatin-induced ototoxicity, and Duchenne muscular dystrophy.